Quantitative Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,342
Closed -$4.14M – 505
2026
Q2
$4.14M Buy
+8,342
New +$3.7M 0.45% 54
2026
Q1
– Sell
-3,657
Closed -$1.66M – 565
2025
Q4
$1.66M Buy
3,657
+1,985
+119% +$856K 0.16% 134
2025
Q3
$654K Buy
+1,672
New +$699K 0.09% 191
2025
Q2
– Sell
-14,997
Closed -$7.27M – 476
2025
Q1
$7.27M Buy
+14,997
New +$6.99M 0.67% 32
2024
Q3
– Sell
-14,306
Closed -$6.7M – 452
2024
Q2
$6.7M Sell
14,306
-6,488
-31% -$2.82M 0.73% 29
2024
Q1
$8.69M Sell
20,794
-32,900
-61% -$13.9M 0.51% 32
2023
Q4
$21.8M Buy
53,694
+50,515
+1,589% +$18.7M 1.26% 16
2023
Q3
$1.1M Sell
3,179
-5,974
-65% -$2.09M 0.17% 105
2023
Q2
$3.22M Sell
9,153
-1,900
-17% -$640K 0.31% 73
2023
Q1
$3.48M Buy
+11,053
New +$3.32M 0.73% 39
2022
Q1
– Sell
-21,622
Closed -$4.75M – 335
2021
Q4
$4.75M Buy
+21,622
New +$4.2M 0.67% 40
2020
Q3
– Sell
-18,876
Closed -$5.48M – 618
2020
Q2
$5.48M Buy
18,876
+13,461
+249% +$3.65M 0.56% 31
2020
Q1
$1.29M Sell
5,415
-177,060
-97% -$40.6M 0.14% 178
2019
Q4
$40M Buy
182,475
+156,614
+606% +$31.7M 1.21% 14
2019
Q3
$4.38M Sell
25,861
-2,918
-10% -$516K 0.23% 120
2019
Q2
$5.28M Buy
28,779
+5,879
+26% +$1.03M 0.2% 123
2019
Q1
$4.21M Buy
+22,900
New +$4.23M 0.24% 115
2018
Q4
– Sell
-25,900
Closed -$4.99M – 840
2018
Q3
$4.99M Buy
25,900
+13,600
+111% +$2.42M 0.18% 92
2018
Q2
$2.09M Buy
12,300
+1,500
+14% +$233K 0.04% 356
2018
Q1
$1.76M Sell
10,800
-111,500
-91% -$18.2M 0.03% 483
2017
Q4
$18.3M Buy
+122,300
New +$18.1M 0.27% 74
2017
Q2
– Sell
-102,100
Closed -$11.2M – 916
2017
Q1
$11.2M Buy
+102,100
New +$8.99M 0.17% 153
2016
Q4
– Sell
-22,100
Closed -$1.93M – 973
2016
Q3
$1.93M Buy
+22,100
New +$2.09M 0.06% 320
2016
Q2
– Sell
-3,600
Closed -$286K – 941
2016
Q1
$286K Buy
+3,600
New +$326K 0.01% 643
2015
Q1
– Sell
-19,900
Closed -$2.36M – 753
2014
Q4
$2.36M Buy
+19,900
New +$2.24M 0.36% 55
2014
Q3
– Sell
-13,500
Closed -$1.28M – 521
2014
Q2
$1.28M Sell
13,500
-7,400
-35% -$519K 0.23% 92
2014
Q1
$1.48M Buy
+20,900
New +$1.66M 0.07% 186

Other funds holding VRTX

Quantitative Investment Management's VRTX Position: Q3 2026 in Review

Quantitative Investment Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 8,342 shares — an estimated $4.14M sold.

Quantitative Investment Management first reported a position in VRTX in Q1 2014 and held it in 27 quarters. The position peaked at $40M in Q4 2019. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Quantitative Investment Management reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Quantitative Investment Management sold 8,342 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.14M.
  • Quantitative Investment Management first reported a position in Vertex Pharmaceuticals in Q1 2014 and held it in 27 quarters.
  • Quantitative Investment Management's Vertex Pharmaceuticals position peaked at $40M in Q4 2019.
  • 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Quantitative Investment Management's 13F filing for Q3 2026, filed 16 Nov 2026.